PlainRecalls
LowClass IIITerminated

FDA Drug recall · Reported February 2, 2022

CTx7 Kit, contains one tube CariFree CTx4 Gel 5000, 1.1% Neutral Sodium Fluoride Mint, 2 oz (57 g) Rx only NDC: 61578-205-01 Manufactured by Oral BioTech Albany, Oregon 97321 and one bottle of CariFree CTx3 Rinse, Mint Anticavity Rinse, 16 fl oz. bottle.

Subpotent Drug: Product contains less Sodium Fluoride than listed on product label.

Recall #
D-0454-2022
Affected scope
3 single tubes of lot 192107 and 3 single tubes of 192108
Initiated
December 3, 2021
Verify with FDA Drug →
View my saved recalls

Dental Alliance Holdings LLC recalled CTx7 Kit, contains one tube CariFree CTx4 Gel 5000, 1.1% Neutral Sodium Fluoride Mint, 2 … — a low-severity action.

CTx7 Kit, contains one tube CariFree CTx4 Gel 5000, 1.1% Neutral Sodium Fluoride Mint, 2 … was recalled by Dental Alliance Holdings LLC in February 2, 2022. Reason: Subpotent Drug: Product contains less Sodium Fluoride than listed on product label.. Check the official notice for the remedy. Verify recall #D-0454-2022 with the FDA Drug before acting.

The recall

Dental Alliance Holdings LLC issued this low-severity FDA Drug recall — Subpotent Drug: Product contains less Sodium Fluoride than listed on product label..

Low
severity level
Class III
classification
February 2, 2022
reported

Sourced from official FDA Drug enforcement records. Verify recall #D-0454-2022 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This FDA Drug action (record #D-0454-2022) was formally reported on February 2, 2022, with the manufacturer initiating the action on December 3, 2021. It is classified under Low severity (Class III), with a current status of Terminated. Dental Alliance Holdings LLC is listed as the recalling firm, operating out of Albany, OR. Federal records list the affected scope as 3 single tubes of lot 192107 and 3 single tubes of 192108.

The documented reason for this recall is: Subpotent Drug: Product contains less Sodium Fluoride than listed on product label. Distribution data in the federal record shows the product reached: Distributed nationwide with the United States. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug — clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Drugs & Medications recalls over time

Where this recall sits in its category — 14,048 drugs & medications recalls on record

-50005001,0001,5002,000 20052009201220152018202120242026 216

Where this recall sits in the database

Severity2366872097High severity (most serious)Moderate severityLow severity
Where this recall sits in the database

Of 100,165 recalls in the database, 23,668 are high severity, 72,097 moderate, and 4,400 low. This recall is classified low severity.

Counts reflect market size and reporting activity, not inherent danger — we do not rank products by risk from raw recall volume.

Severity

Low

Affected scope

3 single tubes of lot 192107 and 3 single tubes of 192108

Related Recalls

6

5 from same agency

Product description

CTx7 Kit, contains one tube CariFree CTx4 Gel 5000, 1.1% Neutral Sodium Fluoride Mint, 2 oz (57 g) Rx only NDC: 61578-205-01 Manufactured by Oral BioTech Albany, Oregon 97321 and one bottle of CariFree CTx3 Rinse, Mint Anticavity Rinse, 16 fl oz. bottle.

Reason for recall

Subpotent Drug: Product contains less Sodium Fluoride than listed on product label.

Recall Profile

Structured summary of the FDA Drug recall record
Attribute Value
Agency U.S. Food and Drug Administration
Severity class Low (Class III)
Status Terminated
Recall number D-0454-2022
Date reported February 2, 2022
Date initiated December 3, 2021
Recalling firm Dental Alliance Holdings LLC
Firm location Albany, OR
Affected scope 3 single tubes of lot 192107 and 3 single tubes of 192108
Distribution Distributed nationwide with the United States

Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

  • Check the recall number (D-0454-2022) and product description against the item you own. Search the archive
  • Confirm the current status with FDA Drug before acting — recall details can be updated.
  • Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled?
CTx7 Kit, contains one tube CariFree CTx4 Gel 5000, 1.1% Neutral Sodium Fluoride Mint, 2 oz (57 g) Rx only NDC: 61578-205-01 Manufactured by Oral BioTech Albany, Oregon 97321 and one bottle of CariFree CTx3 Rinse, Mint Anticavity Rinse, 16 fl oz. bottle.. Recalled by Dental Alliance Holdings LLC. Units affected: 3 single tubes of lot 192107 and 3 single tubes of 192108.
Why was this product recalled?
Subpotent Drug: Product contains less Sodium Fluoride than listed on product label.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 2, 2022. Severity: Low. Recall number: D-0454-2022.
Where was the recalled product distributed?
Distribution: Distributed nationwide with the United States.
How do I check if my product is affected by a recall?
Check the product description and recall number (D-0454-2022) against your product. Visit the official FDA Drug website for the most current information. You can also use our Recall Checker tool to search by product name or brand.
Should I stop using a recalled medication or medical device?
Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nearby Recalls in This Category

Other recalls in the same product category — useful for spotting patterns across the same defect class or manufacturer.

Compare this recall with Nicotine Transdermal System Patch, 14 mg, 14 patches per bo… →

Data Sources

Source: FDA, CPSC, and NHTSA federal recall databases. This recall: FDA Drug, reported February 2, 2022.

  • Source: FDA — Food and Drug Administration, openFDA Enforcement API (food, drug, and medical device recalls)
  • Source: CPSC — Consumer Product Safety Commission Recalls API (consumer product recalls and hazards)
  • Source: NHTSA — National Highway Traffic Safety Administration Recalls API (vehicle safety recalls)

Recall information is sourced from official federal agency databases. Always verify recall details with the issuing agency for the most current status. This information is for research and awareness purposes only.

Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records — no number is typed in by an editor. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of June 2026.